StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.59MP/E –Yield –

MacroGenics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MacroGenics's operating cash flow for the twelve months ending Jun 30, 2026 was -$63.72M. For fiscal 2025 it was -$81.04M. The highest annual figure on record is $14.41M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$81.04M–
FY2024Dec 31, 2024-$68.37M–
FY2023Dec 31, 2023-$78.21M–
FY2022Dec 31, 2022-$86.96M–
FY2021Dec 31, 2021-$143.83M–
FY2020Dec 31, 2020-$111.90M–
FY2019Dec 31, 2019-$134.27M–
FY2018Dec 31, 2018-$153.23M-1163.8%
FY2017Dec 31, 2017$14.41M–
FY2016Dec 31, 2016-$43.68M–
FY2015Dec 31, 2015-$13.66M–
FY2014Dec 31, 2014-$32.76M–
FY2013Dec 31, 2013-$14.17M–
FY2012Dec 31, 2012-$6.58M-197.4%
FY2011Dec 31, 2011$6.76M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.75M–
Q1 FY2026Mar 31, 2026-$35.81M–
Q4 FY2025Dec 31, 2025$43.02M–
Q3 FY2025Sep 30, 2025-$30.19M-150.2%
Q2 FY2025Jun 30, 2025-$46.99M–
Q1 FY2025Mar 31, 2025-$46.89M–
Q4 FY2024Dec 31, 2024-$38.41M–
Q3 FY2024Sep 30, 2024$60.16M–
Q2 FY2024Jun 30, 2024-$44.49M–
Q1 FY2024Mar 31, 2024-$45.64M–
Q4 FY2023Dec 31, 2023-$28.04M-195.6%
Q3 FY2023Sep 30, 2023-$35.25M–
Q2 FY2023Jun 30, 2023-$2.09M–
Q1 FY2023Mar 31, 2023-$12.83M–
Q4 FY2022Dec 31, 2022$29.32M–
Q3 FY2022Sep 30, 2022-$9.42M–
Q2 FY2022Jun 30, 2022-$49.16M–
Q1 FY2022Mar 31, 2022-$57.70M–
Q4 FY2021Dec 31, 2021-$54.31M–
Q3 FY2021Sep 30, 2021-$14.80M–
Q2 FY2021Jun 30, 2021-$45.69M–
Q1 FY2021Mar 31, 2021-$29.04M–
Q4 FY2020Dec 31, 2020-$5.53M–
Q3 FY2020Sep 30, 2020-$25.68M–
Q2 FY2020Jun 30, 2020-$36.55M–
Q1 FY2020Mar 31, 2020-$44.14M–
Q4 FY2019Dec 31, 2019-$38.04M–
Q3 FY2019Sep 30, 2019-$17.39M–
Q2 FY2019Jun 30, 2019-$48.84M–
Q1 FY2019Mar 31, 2019-$30.00M–
Q4 FY2018Dec 31, 2018-$27.23M-124.3%
Q3 FY2018Sep 30, 2018-$36.98M–
Q2 FY2018Jun 30, 2018-$57.73M–
Q1 FY2018Mar 31, 2018-$31.30M–
Q4 FY2017Dec 31, 2017$111.85M–
Q3 FY2017Sep 30, 2017-$31.35M-163.0%
Q2 FY2017Jun 30, 2017-$30.76M–
Q1 FY2017Mar 31, 2017-$35.33M–
Q4 FY2016Dec 31, 2016-$28.33M–
Q3 FY2016Sep 30, 2016$49.79M–

More MacroGenics figures

See a number that looks wrong?